Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 million for a 20-25% stake in critical care drugs provider Samarth Life Sciences, three people...
Cipla, Alkem Laboratories in final lap to buy SMT
Drugmakers Cipla and Alkem Laboratories have emerged as the frontrunners to acquire a controlling stake in Sahajanand Medical Technologies (SMT), India’s largest cardiac stent maker, said people in the know. This...
France considering stake in Sanofi’s Opella, minister says
France is considering taking a stake in Sanofi’s Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker’s plans to sell a 50% stake in Opella to a U.S. private equity...
Vanda Pharmaceuticals rejects Cycle Pharma’s second takeover offer
Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda’s stock following the FDA’s...
PE firms queue up for Novartis’ Indian arm
Private equity firms ChrysCapital, Apollo Global Management, Kedaara Capital and Multiples Equity are evaluating the acquisition of Novartis AG’s 70.68% stake in its India-listed arm, according to the people with...
CCI clears Rs 13,630 cr Mankind Pharma acquisition of Bharat Serums
The Competition Commission of India (CCI) has cleared Mankind Pharma’s acquisition of Bharat Serums and Vaccines in a ₹13,630-crore deal. In a statement on Wednesday, the regulator said: “The proposed...
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal
The Competition Commission of India (CCI) on Tuesday approved the proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for Rs 13,630 crore. Listed firm Mankind Pharma is engaged in developing...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.6%...
Dr Reddy’s Laboratories completes acquisition of Haleon’s NRT portfolio
Dr Reddy’s Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc’s global portfolio of consumer healthcare brands, outside of the US, in the Nicotine...
Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger
Sequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will create a platform with leadership in animal pharmaceuticals, end-to-end...
Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 cr
Aurobindo Pharma Ltd on Wednesday said it will acquire the balance 49 per cent stake in GLS Pharma Ltd for Rs 22.5 crore to make the latter a wholly-owned subsidiary. The company has entered into a binding agreement on...
Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma Ltd on Wednesday said its Canadian subsidiary acquired 40 million shares in eGenesis Inc., a biotechnology company at the forefront of xenotransplantation focused on developing safe and effective human...
